SCHEMBL21116823

SCHEMBL21116823

c1ccc2c(c1)ccc1oc3cc(-c4nc(-c5ccc6c(c5)oc5ccccc56)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc3c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
AHR P35869 3/20 0.44
MEN1 O00255 3/20 0.42
MAPT P10636 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
ABCG2 Q9UNQ0 5/20 0.42
PAX8 Q06710 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
FYN P06241 1/20 0.42
MAPK3 P27361 1/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
HCRTR1 O43613 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DUSP3 P51452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24185078 0.92 TDP1 (0.43) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL25066736 0.91 ABCG2 (0.49) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL25660738 0.90 AHR (0.41) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL26048040 0.90 TDP1 (0.45) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL15501325 0.88 ABCG2 (0.47) TDP1L3MBTL1AHRMAPTKDM4E
SCHEMBL24372779 0.88 TDP1 (0.46) TDP1L3MBTL1AHRMEN1KMT2A
SCHEMBL20127580 0.88 TDP1 (0.50) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL26047982 0.88 AHR (0.46) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL25660741 0.88 PLA2G2A (0.40) TDP1L3MBTL1AHRMEN1MAPT
SCHEMBL20064143 0.87 ABCG2 (0.46) TDP1L3MBTL1AHRMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 TDP1 2599/4885L3MBTL1 3450/4885AHR 2690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.